BridgeMD
Compares treatment options for Gastric Adenoma
Official title Argon Plasma Coagulation Versus Endoscopic Mucosal Resection for Gastric Adenoma (CLER-GA)
ClinicalTrials.gov ID: NCT07161479
What this study is testing
- What it's testing
- Gastric adenomas with low-grade dysplasia (LGD) are considered precancerous lesions of the stomach. While these lesions carry a lower risk of progressing to gastric cancer compared with high-grade dysplasia, there is still uncertainty about the best way to manage them.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 20 and older
You may be able to join if
- Adults aged 20 years or older
- Diagnosed with gastric adenoma with low-grade dysplasia measuring ≤ 1 cm on endoscopy
- Scheduled to undergo endoscopic treatment
- Able and willing to provide written informed consent
You likely can't join if
- Previous treatment for gastric adenoma or gastric cancer
- History of gastrectomy
- Diagnosis of gastric cancer or high-grade dysplasia at the time of enrollment
- Presence of multiple gastric adenomas
- Pregnant, breastfeeding, or possibility of pregnancy
- Uncontrolled chronic illnesses that may interfere with trial participation (e.g., uncontrolled hypertension, uncontrolled diabetes, chronic kidney...
The study team makes the final eligibility decision.
Where it's taking place
- Goyang-si, South Korea
- Seoul, South Korea
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 20 years and older. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Goyang-si, South Korea; Seoul, South Korea. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.